Ofatumumab
1 NDC across 1 manufacturer|0 Generic,1 Brand
Ofatumumab is used to treat lymphoid leukemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $583 million on Ofatumumab across 60,000 claims for 7,188 beneficiaries.
Ofatumumab is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $24369.37 to $24369.37 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$24369.37 – $24369.37
per ML
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Novartis Pharmaceuticals Corporation manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing OFATUMUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KESIMPTA 20 MG/0.4 ML PEN | $24369.3694 per ML | -0.04% |
Frequently Asked Questions
What is Ofatumumab used to treat?
Ofatumumab is used to treat lymphoid leukemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Ofatumumab?
In 2024, Medicare Part D spent $583 million on Ofatumumab across 60,000 claims for 7,188 beneficiaries.
How many Ofatumumab products are on the market?
The Ofatumumab drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ofatumumab?
NADAC reference prices for Ofatumumab range from $24369.3694 to $24369.3694 per ML.
Which manufacturers make Ofatumumab?
1 manufacturer lists Ofatumumab in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (1).
How has the price of Ofatumumab changed recently?
Over the past 7 days, 0 Ofatumumab NDCs rose and 1 fell, with a market-wide average change of -0.0%.